BIOGEN INC

SUMMARY

Biogen develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company products address diseases such as multiple sclerosis, non-hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.

DEALS OVERVIEW

• Total Value

  £10,916M

• Volume

  7

• Average Deal Size

  £1,559M